Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Boer

Showing results (671-680 of 719) with videos related to

Pageof 72
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer ConsortiumD J A Lobbezoo, R J W van Kampen, A C Voogd, et al.
Atherosclerosis|April 10, 2024
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPNM Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPNM Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, et al.
Paleoceanography and Paleoclimatology|August 2, 2022
African Hydroclimate During the Early Eocene From the DeepMIP SimulationsCharles J R Williams, Daniel J Lunt, Ulrich Salzmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2012
Relevant impact of central pathology review on nodal classification in individual breast cancer patientsJ H M J Vestjens, M J Pepels, M de Boer, et al.
The Lancet. Oncology|July 12, 2016
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trialStephanie M de Boer, Melanie E Powell, Linda Mileshkin, et al.
Breast (Edinburgh, Scotland)|January 15, 2019
A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherlands Advanced Breast Cancer registryL M Knapen, S M E Geurts, K I E Ibragimova, et al.
Digestive Diseases (Basel, Switzerland)|October 15, 2024
Treatment of Colorectal Lung Metastases: Two Centers Retrospective StudyMyrtle F Krul, Jan M van Rees, Amihan M de Boer, et al.
British Journal of Cancer|April 17, 2015
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?D J A Lobbezoo, R J W van Kampen, A C Voogd, et al.
British Journal of Cancer|January 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistryLisa Vermij, Jan J Jobsen, Alicia León-Castillo, et al.
Pageof 72

Showing results (671-680 of 719) with videos related to

Sort By:
Pageof 72
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer ConsortiumD J A Lobbezoo, R J W van Kampen, A C Voogd, et al.
Atherosclerosis|April 10, 2024
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPNM Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2023
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPNM Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, et al.
Paleoceanography and Paleoclimatology|August 2, 2022
African Hydroclimate During the Early Eocene From the DeepMIP SimulationsCharles J R Williams, Daniel J Lunt, Ulrich Salzmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2012
Relevant impact of central pathology review on nodal classification in individual breast cancer patientsJ H M J Vestjens, M J Pepels, M de Boer, et al.
The Lancet. Oncology|July 12, 2016
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trialStephanie M de Boer, Melanie E Powell, Linda Mileshkin, et al.
Breast (Edinburgh, Scotland)|January 15, 2019
A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherlands Advanced Breast Cancer registryL M Knapen, S M E Geurts, K I E Ibragimova, et al.
Digestive Diseases (Basel, Switzerland)|October 15, 2024
Treatment of Colorectal Lung Metastases: Two Centers Retrospective StudyMyrtle F Krul, Jan M van Rees, Amihan M de Boer, et al.
British Journal of Cancer|April 17, 2015
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?D J A Lobbezoo, R J W van Kampen, A C Voogd, et al.
British Journal of Cancer|January 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistryLisa Vermij, Jan J Jobsen, Alicia León-Castillo, et al.
Pageof 72